Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

Market Cap	5.74B +14.0%
Revenue (ttm)	2.79B -19.9%
Net Income	77.30M -60.0%
EPS	0.20 -61.2%
Shares Out	379.33M
PE Ratio	76.62
Forward PE	n/a
Dividend	0.30 (1.98%)
Ex-Dividend Date	Sep 17, 2025

Volume	7,691,894
Average Volume	6,225,859
Open	14.75
Previous Close	14.84
Day's Range	14.71 - 15.17
52-Week Range	13.27 - 23.22
Beta	0.49
RSI	49.21
Earnings Date	Mar 27, 2026

About SHE:300233

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China.

• Industry: Chemicals
• Sector: Materials
• Founded: 2004
• Employees: 3,657
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300233

Financial Performance

In 2024, SHE:300233's revenue was 3.37 billion, a decrease of -4.66% compared to the previous year's 3.54 billion. Earnings were 196.78 million, an increase of 12.63%.